|
BM-MSC
|
AD-MSC
|
L-MSC
|
---|
CD19-
|
99.29%
|
99.74%
|
99.98%
|
CD29+
|
99.00%
|
99.48%
|
99.63%
|
CD34-
|
96.76%
|
98.30%
|
99.62%
|
CD45-
|
95.38%
|
98.40%
|
88.77%
|
Sca1+
|
58.46%
|
53.29%
|
38.76%
|
- BM-MSC: bone marrow-derived mesenchymal stem (stromal) cells; AD-MSC: adipose tissue-derived mesenchymal stem (stromal) cells; L-MSC: lung tissue-derived mesenchymal stem (stromal) cells. Flow cytometry reveals that mesenchymal stem cells are negative (−) for leukocyte (CD45), hematopoietic (CD34), and B-cells (CD19), while they are concomitantly positive (+) for stem cell (Sca1) and mesenchymal stem cell markers (CD29).